Elif Karaaslan

555 total citations
20 papers, 377 citations indexed

About

Elif Karaaslan is a scholar working on Infectious Diseases, Ecology, Evolution, Behavior and Systematics and Epidemiology. According to data from OpenAlex, Elif Karaaslan has authored 20 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 5 papers in Ecology, Evolution, Behavior and Systematics and 5 papers in Epidemiology. Recurrent topics in Elif Karaaslan's work include Viral Infections and Vectors (11 papers), Viral Infections and Outbreaks Research (9 papers) and Vector-Borne Animal Diseases (5 papers). Elif Karaaslan is often cited by papers focused on Viral Infections and Vectors (11 papers), Viral Infections and Outbreaks Research (9 papers) and Vector-Borne Animal Diseases (5 papers). Elif Karaaslan collaborates with scholars based in Türkiye, United States and Uganda. Elif Karaaslan's co-authors include Sibel Döşler, A. Alev Gerçeker, Mehmet Ziya Doymaz, Éric Bergeron, Ümit Zeybek, Aykut Özdarendeli, JoAnn D. Coleman-McCray, Faruk Karakeçili, Bülent Durdu and Ali Osman Kılıç and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Journal of Virology.

In The Last Decade

Elif Karaaslan

17 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elif Karaaslan Türkiye 8 175 166 98 58 39 20 377
Arno Koenigs Germany 7 61 0.3× 29 0.2× 157 1.6× 170 2.9× 29 0.7× 8 363
Satomi Yamada Japan 7 369 2.1× 165 1.0× 184 1.9× 34 0.6× 11 0.3× 17 594
Sheeba Santhini Manoharan-Basil Belgium 16 70 0.4× 369 2.2× 114 1.2× 77 1.3× 6 0.2× 74 565
A. J. Monteiro Brazil 15 82 0.5× 42 0.3× 153 1.6× 14 0.2× 53 1.4× 20 478
Laura A. Gallagher Ireland 6 283 1.6× 91 0.5× 222 2.3× 49 0.8× 8 0.2× 6 435
Maria Elena Della Pepa Italy 8 76 0.4× 35 0.2× 106 1.1× 28 0.5× 38 1.0× 11 340
Frédéric Schramm France 10 98 0.6× 17 0.1× 186 1.9× 40 0.7× 23 0.6× 33 421
Shamsaldeen Ibrahim Saeed Sudan 9 67 0.4× 46 0.3× 59 0.6× 18 0.3× 8 0.2× 20 250
Antoine Grillon France 9 55 0.3× 15 0.1× 105 1.1× 87 1.5× 33 0.8× 30 327
Joseph J. Dajcs United States 15 216 1.2× 62 0.4× 183 1.9× 77 1.3× 20 0.5× 24 622

Countries citing papers authored by Elif Karaaslan

Since Specialization
Citations

This map shows the geographic impact of Elif Karaaslan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elif Karaaslan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elif Karaaslan more than expected).

Fields of papers citing papers by Elif Karaaslan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elif Karaaslan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elif Karaaslan. The network helps show where Elif Karaaslan may publish in the future.

Co-authorship network of co-authors of Elif Karaaslan

This figure shows the co-authorship network connecting the top 25 collaborators of Elif Karaaslan. A scholar is included among the top collaborators of Elif Karaaslan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elif Karaaslan. Elif Karaaslan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Karaaslan, Elif, Florine E. M. Scholte, Teresa E. Sorvillo, et al.. (2024). Crimean-Congo hemorrhagic fever virus replicon particle vaccine is safe and elicits functional, non-neutralizing anti-nucleoprotein antibodies and T cell activation in rhesus macaques. Antiviral Research. 233. 106045–106045. 1 indexed citations
3.
Kainulainen, Markus H., Jessica R. Harmon, Elif Karaaslan, et al.. (2024). A public, cross‐reactive glycoprotein epitope confounds Ebola virus serology. Journal of Medical Virology. 96(10). e29946–e29946.
4.
Bergeron, Éric, Cheng‐Feng Chiang, Michael K. Lo, et al.. (2024). Streamlined detection of Nipah virus antibodies using a split NanoLuc biosensor. Emerging Microbes & Infections. 13(1). 2398640–2398640. 3 indexed citations
5.
Garrison, Aura R., Vanessa Moresco, Xiankun Zeng, et al.. (2024). Nucleocapsid protein-specific monoclonal antibodies protect mice against Crimean-Congo hemorrhagic fever virus. Nature Communications. 15(1). 1722–1722. 8 indexed citations
6.
Karaaslan, Elif, Teresa E. Sorvillo, Florine E. M. Scholte, et al.. (2024). Crimean Congo hemorrhagic fever virus nucleoprotein and GP38 subunit vaccine combination prevents morbidity in mice. npj Vaccines. 9(1). 148–148. 3 indexed citations
7.
Sorvillo, Teresa E., Elif Karaaslan, Florine E. M. Scholte, et al.. (2024). Replicon particle vaccination induces non-neutralizing anti-nucleoprotein antibody-mediated control of Crimean-Congo hemorrhagic fever virus. npj Vaccines. 9(1). 88–88. 5 indexed citations
8.
Karaaslan, Elif, et al.. (2024). Cellular immunity to nucleoproteins (NP) of Crimean-Congo hemorrhagic fever virus (CCHFV) and Hazara Virus (HAZV). Medical Microbiology and Immunology. 213(1). 20–20. 2 indexed citations
9.
Scholte, Florine E. M., Sergio E. Rodriguez, Stephen R. Welch, et al.. (2023). Characterization of Humoral Responses to Nipah Virus Infection in the Syrian Hamster Model of Disease. The Journal of Infectious Diseases. 230(2). 438–443. 6 indexed citations
10.
Kainulainen, Markus H., Jessica R. Harmon, Éric Bergeron, et al.. (2023). Recombinant Sudan virus and evaluation of humoral cross-reactivity between Ebola and Sudan virus glycoproteins after infection or rVSV-ΔG-ZEBOV-GP vaccination. Emerging Microbes & Infections. 12(2). 2265660–2265660. 3 indexed citations
11.
Welch, Stephen R., Jessica R. Spengler, JoAnn D. Coleman-McCray, et al.. (2023). Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccination. Science Advances. 9(31). eadh4057–eadh4057. 18 indexed citations
12.
13.
14.
Karaaslan, Elif, Faruk Karakeçili, Aykut Özdarendeli, et al.. (2021). Immune responses in multiple hosts to Nucleocapsid Protein (NP) of Crimean-Congo Hemorrhagic Fever Virus (CCHFV). PLoS neglected tropical diseases. 15(12). e0009973–e0009973. 17 indexed citations
15.
Koç, Meliha Meriç, et al.. (2020). Discordance between Serum Neutralizing Antibody Titers and the Recovery from COVID-19. The Journal of Immunology. 205(10). 2719–2725. 14 indexed citations
16.
17.
Doymaz, Mehmet Ziya & Elif Karaaslan. (2019). Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria. Infectious Diseases. 51(9). 676–682. 14 indexed citations
18.
Döşler, Sibel, Elif Karaaslan, & A. Alev Gerçeker. (2015). Antibacterial and anti-biofilm activities of melittin and colistin, alone and in combination with antibiotics against Gram-negative bacteria. Journal of Chemotherapy. 28(2). 95–103. 77 indexed citations
19.
Döşler, Sibel & Elif Karaaslan. (2014). Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides. Peptides. 62. 32–37. 183 indexed citations
20.
Karaaslan, Elif, et al.. (2002). Türkiye’de Birincil Halka Arz Uygulamalarının Analizi. İktisat İşletme ve Finans. 17(201).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arno Koenigs Breakdown of academic impact, for papers by Satomi Yamada Breakdown of academic impact, for papers by Sheeba Santhini Manoharan-Basil Breakdown of academic impact, for papers by A. J. Monteiro Breakdown of academic impact, for papers by Laura A. Gallagher Breakdown of academic impact, for papers by Maria Elena Della Pepa Breakdown of academic impact, for papers by Frédéric Schramm Breakdown of academic impact, for papers by Shamsaldeen Ibrahim Saeed Breakdown of academic impact, for papers by Antoine Grillon Breakdown of academic impact, for papers by Joseph J. Dajcs
Rankless by CCL
2026